Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymph Node Mapping”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00625625
What this trial is testing

Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer
Saint John's Cancer Institute 225
Post-approval studies (Phase 4)UnknownNCT04261179
What this trial is testing

Study Comparing Lymphoseek® vs. Albumin Nanocolloid in Head and Neck, Melanoma and Breast Cancer

Who this might be right for
Head CancerNeck CancerMelanoma+1 more
Anna Cruceta 30
Not applicableNot Yet RecruitingNCT07054944
What this trial is testing

Tumor-Lymph Node Mapping

Who this might be right for
Pediatric Solid TumorsRhabdomyosarcomaSarcoma+1 more
University of Rochester 10
Testing effectiveness (Phase 2)Ended earlyNCT01276054
What this trial is testing

Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.

Who this might be right for
LymphedemaRecurrent Breast CancerStage IA Breast Cancer+2 more
University of Southern California 4
Large-scale testing (Phase 3)Study completedNCT00003325
What this trial is testing

Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the Vulva

Who this might be right for
Vulvar Cancer
Gynecologic Oncology Group 515
Not applicableStudy completedNCT00608920
What this trial is testing

Single Photon Emission Computed Tomography (SPECT) Lymph Node Mapping

Who this might be right for
Adenocarcinoma of the Prostate
Washington University School of Medicine 15
Not applicableStudy completedNCT05746156
What this trial is testing

Lymphatic Mapping for Image Guided Radiotherapy in Patients With LACC - a Feasibility Study

Who this might be right for
Locally Advanced Cervical Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 17
Not applicableStudy completedNCT03619967
What this trial is testing

Sentinel Lymph Node Mapping With Near Infrared Fluorescent Markers

Who this might be right for
Breast Cancer
University of Illinois at Urbana-Champaign 31
Very early researchLooking for participantsNCT05645523
What this trial is testing

Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors

Who this might be right for
Solid Tumor
St. Jude Children's Research Hospital 25
Not applicableStudy completedNCT00631241
What this trial is testing

Analysis of Parametrial Lymph Nodes as Sentinel Nodes in Patients With Cervical Cancer

Who this might be right for
Cervical Cancer
M.D. Anderson Cancer Center 20
Not applicableStudy completedNCT02209532
What this trial is testing

A Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Patients With Uterine and Cervical Malignancies Who Are Undergoing Lymph Node Mapping

Who this might be right for
Endometrial CancerUterine CancerCervical Cancer
Novadaq Technologies ULC, now a part of Stryker 180
Testing effectiveness (Phase 2)UnknownNCT01038908
What this trial is testing

Breast Lymph Node Mapping

Who this might be right for
Breast Cancer
University of British Columbia 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT02106598
What this trial is testing

Targeted Silica Nanoparticles for Real-Time Image-Guided Intraoperative Mapping of Nodal Metastases

Who this might be right for
Head and Neck Melanoma
Memorial Sloan Kettering Cancer Center 67
Not applicableLooking for participantsNCT04688528
What this trial is testing

Dose De-escalation and Sentinel LN Mapping Driven Radiotherapy of Contralateral Neck in Ipsilateral Node Positive HNSCC

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Universitaire Ziekenhuizen KU Leuven 147
Testing effectiveness (Phase 2)Study completedNCT00832429
What this trial is testing

Lymph Node Mapping in Finding Metastatic Disease in Patients With Sebaceous Gland Cancer of the Eyelid

Who this might be right for
Eyelid Sebaceous Gland Carcinoma
M.D. Anderson Cancer Center 20
Not applicableStudy completedNCT00595725
What this trial is testing

Intra-Operative Lymphatic Mapping in Patients With Invasive Carcinoma of the Cervix or Endometrial Carcinoma

Who this might be right for
Cervical CancerEndometrial CancerCervical Carcinoma
Memorial Sloan Kettering Cancer Center 151
Large-scale testing (Phase 3)Study completedNCT03200704
What this trial is testing

A Study Assessing the Safety and Effectiveness of IC2000 and SPY Fluorescence Imaging Systems (SPY-PHI) in the Visualization of Lymphatic Vessels and Identification of Lymph Nodes During Sentinel Lymph Node Biopsy in Subjects With Breast Cancer

Who this might be right for
Breast CancerLymph Node MappingSentinel Lymph Node Biopsy
Novadaq Technologies ULC, now a part of Stryker 152
Not applicableUnknownNCT06163963
What this trial is testing

Sentinel Lymph Node in Early-Stage Endometrium Cancer

Who this might be right for
Sentinel Lymph NodeEndometrial Cancer
Istanbul University 100
Not applicableActive Not RecruitingNCT04400292
What this trial is testing

Sentinel Lymph Node Mapping in Esophageal Cancer Using ICG Dye and NIR Imaging

Who this might be right for
Esophageal Cancer
Memorial Sloan Kettering Cancer Center 90
Not applicableStudy completedNCT01823172
What this trial is testing

Second Echelon Node Study With Methylene Blue

Who this might be right for
Breast CancerMelanoma
Mayo Clinic 21
Next Page